Unveiled: The Moveable Middle on Animal Research Is Larger Than We Thought

June 16, 2021 This guest post was written by Matthew R. Bailey, president; Eva Maciejewski, director of communications; and Leah Jessen, digital communication manager, Foundation for Biomedical Research The research community has a prime opportunity to educate the so-called moveable middle with facts about why animal research is necessary for medical advancements, polling data show. … Continue reading Unveiled: The Moveable Middle on Animal Research Is Larger Than We Thought

Puberty blockers are all over the news (and laws). How did they come about?

June 4th 2021 June is Pride Month! 🏳️‍🌈 And this year, Pride Month follows a particularly tumultuous legislative period in the U.S with respect to LGBTQIA health. Recently, news about states introducing or passing legislation to restrict or ban the use of medical treatments aimed at treating transgender youth has been fast and furious. Lawmakers … Continue reading Puberty blockers are all over the news (and laws). How did they come about?

FDA approves lung cancer drug #MPAR

June 3rd 2021 Recently, the FDA approved an Amgen drug, sotorasib, for non-small cell lung cancer (NSCLS) with a specific mutation in a gene known as Kirsten rat sarcoma viral oncogene homolog (KRAS) in patients whose disease has worsened after treatment with chemotherapy or other medicines. This mutation accounts for 13% of NSCLS—the most common … Continue reading FDA approves lung cancer drug #MPAR